• Explore /
  • Poster
  • / FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF, FLOT therapy for locally advanced esophageal carcinoma (JCOG1804E)—Short-term results for cohorts C and D.

FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF, FLOT therapy for locally advanced esophageal carcinoma (JCOG1804E)—Short-term results for cohorts C and D.

Abstract Poster

Authors

null

Satoru Matsuda

Department of Surgery, Keio University School of Medicine, Tokyo, Japan

Satoru Matsuda , Shun Yamamoto , Ken Kato , Hiroyuki Daiko , Takashi Kojima , Hiroki Hara , Tetsuya Abe , Yasuhiro Tsubosa , Hirofumi Kawakubo , Kengo Nagashima , Kazunori Aoki , Shinichi Yachida , Yuko Kitagawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03914443

DOI

10.1200/JCO.2022.40.4_suppl.286

Abstract #

286

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Takako Yoshii

First Author: Shun Yamamoto

First Author: Manabu Muto

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.

First Author: Yuri Yoshinami